Showing results (631-640 of 1,983) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|June 13, 2015
Future directions of acute ischaemic stroke therapyMarc Fisher, Jeffrey L Saver
The Lancet. Neurology|April 22, 2015
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatmentJavier Pagonabarraga, Jaime Kulisevsky, Antonio P Strafella, et al.
The Lancet. Neurology|May 31, 2015
Natural history of multiple system atrophy in the USA: a prospective cohort studyPhillip A Low, Stephen G Reich, Joseph Jankovic, et al.
The Lancet. Neurology|May 22, 2021
Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studiesLinxin Li, Michael T C Poon, Neshika E Samarasekera, et al.
The Lancet. Neurology|February 13, 2023
Endovascular thrombectomy for basilar artery occlusion: translating research findings into clinical practiceFana Alemseged, Thanh N Nguyen, Shelagh B Coutts, et al.
The Lancet. Neurology|November 15, 2016
Impaired consciousness in patients with absence seizures investigated by functional MRI, EEG, and behavioural measures: a cross-sectional studyJennifer N Guo, Robert Kim, Yu Chen, et al.
The Lancet. Neurology|November 15, 2016
MicroRNAs in epilepsy: pathophysiology and clinical utilityDavid C Henshall, Hajo M Hamer, R Jeroen Pasterkamp, et al.
The Lancet. Neurology|May 6, 2014
Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind studyPeter A Calabresi, Bernd C Kieseier, Douglas L Arnold, et al.
The Lancet. Neurology|April 1, 2014
Gardens that take care of usAdrian Burton
The Lancet. Neurology|April 1, 2014
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trialDavid Michelson, Ellen Snyder, Erin Paradis, et al.
Pageof 199